The Influence of Conversation Map on the Health Behaviors of Diabetes Patients
NCT ID: NCT02977130
Last Updated: 2016-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
615 participants
INTERVENTIONAL
2014-05-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Map group
patients receiving general shared care for diabetes and the conversation map intervention
Map group
diabetes shared care plus conversation map intervention
Control group
patients receiving general shared care for diabetes
Control group
diabetes shared care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Map group
diabetes shared care plus conversation map intervention
Control group
diabetes shared care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Science and Technology, Taiwan
OTHER_GOV
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jiun-Hau Huang, SM, ScD
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201404062RINB
Identifier Type: -
Identifier Source: org_study_id